Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03884985 · ClinicalTrials.gov registry record · NA

Eye Movements, Visual Perception and Attention

A NA study, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
155
Enrollment target

NCT03884985: Completed NA study, sponsored by University of Rochester.

NCT03884985 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 155 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03884985, a NA study, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
155 participants
Enrollment target

Study Summary

During visual fixation, small eye movements of which we are usually not aware, prevent the maintenance of a steady direction of gaze. These eye movements are finely controlled and shift retinal projection of objects within the fovea, the region of the retina where visual acuity is highest. This program of research examines the link between these eye movements and attention, and tests the hypothesis that attention, similarly to eye movements, can be controlled at the foveal level. Psychophysical experiments with human subjects, using state-of-the-art techniques, high resolution eyetracking and retinal stabilization are conducted to address these questions. Gaze-contingent calibration procedures are employed to achieve high accuracy in gaze localization. A custom developed gaze-contingent display is used to shift in real-time visual stimuli on the monitor to compensate for the observer eye movements during fixation periods and to maintain stimuli at a desired location on the retina. Experiments involve visual discrimination/detection tasks with stimuli presented at selected eccentricities within the fovea. Participants' performance and reaction times are examined under different conditions, in which various types of attention are manipulated. In addition to advancing our basic understanding of visual perception, this research leads to a better understanding of attentional control at the foveal scale and of the contribution of microscopic eye movements to the acquisition and processing of visual details.

Primary Outcome

Proportion correct responses in visual tasks. For each visual stimulus presentation, observers performed a four-alternative forced-choice (4AFC) task. A trial was considered correct if the participant's selected response matched the identity of the presented stimulus; otherwise, it was marked as incorrect.

Interventions

  • OTHER Visual stimulation

Trial Details

FieldValue
Enrollment Target 155 participants
Start Date 2018-01-01
Est. Completion 2024-02-01
Phase NA
University of Rochester

636 total trials

What the finished NCT03884985 record still lists

NCT03884985 is an interventional study that assigns participants to a tested intervention. The registered 155 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 1 intervention - of which Visual stimulation is the first listed.

NCT03884985 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03884985 about?

NCT03884985 is a clinical study titled "Eye Movements, Visual Perception and Attention". During visual fixation, small eye movements of which we are usually not aware, prevent the maintenance of a steady direction of gaze. These eye movements are finely controlled and shift retinal projection of objects within the fovea, the region of the retina where visual acuity is highest. This prog...

What is the current status of trial NCT03884985?

This trial is currently completed. It is a NA study. The enrollment target is 155 participants. The study started on 2018-01-01. Estimated completion is 2024-02-01.

What interventions are being tested in trial NCT03884985?

The interventions under investigation include: Visual stimulation (OTHER).

Who is sponsoring clinical trial NCT03884985?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03884985's enrollment target sits among peer trials

155 656th of 2000 higher than 1,345 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03223610 · 155 participants · Phase 1

    Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

  • NCT05072483 · 155 participants

    Natural History Study of CADASIL

  • NCT05086497 · 155 participants · NA

    WBSI Guided Personalized Delivery of TTFields

  • NCT05412069 · 155 participants · NA

    Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03884985, the US trial registry maintained by the National Library of Medicine. NCT03884985 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.